Canada pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
The archive
Page 5 of 170 of this archive, newest first.
What the trials monitored, and what that implies about routine practice
The argument for a baseline panel is that it makes every subsequent result interpretable. The argument against frequent monitoring is that noise accumulates faster than…
Isobaric substitutions: identical masses, different molecules
Deamidation adds 0.98 daltons. On a low-resolution instrument at incretin molecular weights, that is inside the noise.
What STEP 4 and SURMOUNT-4 actually established
A plateau at an intermediate dose and a plateau at the maximum dose look identical from the outside and mean different things.
A supplier suspends shipping to Australia after 11 consecutive customs detentions
The route did not close because of a rule about peptides.
What a 9% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
VendorInvestigate result on a Chengdu retatrutide lot lands 3.0 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
The 17-day notice: how a compounding wind-down works in Mexico
The document is four pages. Three of them are about dates.
Who signed this, and what did they undertake by signing it
Somebody has to be answerable for a release document. On most certificates in this market, nobody is named at all.
Reading the exenatide composition data without the press release
A substudy powered to describe a mean is not a substudy powered to detect a clinically meaningful individual change.
The 8-day notice: how a compounding wind-down works in Norway
The document is four pages. Three of them are about dates.
Nantong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a ERP cagrilintide lot at 98.8%, against 97.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
What the anaesthetists said, and then said again
What endoscopic and ultrasound studies found about residual gastric content, and what the aspiration data does and does not support.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What changed at SGN in June, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Xianning semaglutide lot lands 4.4 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
Inspectors cite Halvard & Pike Apothecary of Portland, Maine over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Why the independent testing market grew a chemistry arm and not a microbiology one
Four independent services underpin confidence in this market. All four are competent at chemistry. Microbiology is a different accreditation, a different facility and a…
The convention nobody explains before handing over the vial
Insulin syringes are graduated in units on a convention that fixes 100 units to one millilitre. That convention says nothing about how much peptide is in a unit, and…
Disregard limits: what a regulated laboratory does with a tiny peak
Baseline placement under a tailing peak is a judgement call with a direct effect on the area. It is one of the few places where two competent analysts genuinely disagree.
A supplier suspends shipping to Canada after 9 consecutive customs detentions
The route did not close because of a rule about peptides.
Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Ireland caps tirzepatide prescribing to 5 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What a 1 mL syringe does that a 0.3 mL syringe does not
The graduation interval differs between barrel sizes, and a 1 mL barrel is frequently marked in two-unit steps. Reading one as though it were marked in single units halves…
How a claim degrades between the bench and the listing
A badge asserts that something was tested. It does not assert what, when, on whose sample, by what method, or whether the lot on sale is the lot that was tested.
What the new Turkey guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Xianning: 10 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a Homopeptide semaglutide lot at 96.0%, against 92.4% on the certificate
The result is unremarkable. What the report omits is not.